BioNTech founders warn of Pfizer vaccine supply issues in EU
Shot has been slow to arrive in the EU due to relatively slow approval from regulators
Source: irishtimes.com
Stay updated with breaking news from Pharma Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shot has been slow to arrive in the EU due to relatively slow approval from regulators